LITTLE FALLS, N.J.,
Feb. 27, 2020 /PRNewswire/
-- CANTEL MEDICAL CORP. (NYSE: CMD) announced today
that in line with its focus on key growth opportunities,
Seth Yellin has been promoted to the
newly created role of Executive Vice President and Chief Growth
Officer. Mr. Yellin will continue to be based in Little Falls, NJ and serve on the Executive
Leadership Team.
Mr. Yellin's primary responsibilities in this expanded role will
be identifying and supporting both organic and inorganic
initiatives to drive the Company's growth objectives. Mr. Yellin
and his team will continue to lead the development of the overall
corporate strategy as well as Cantel's acquisition
program.
"During Seth's seven years of service at Cantel, he has made
significant contributions to the overall execution of our corporate
strategy and has deep knowledge of all our businesses," said
George Fotiades, President and
CEO. "We see enormous untapped potential in our core markets
representing the opportunity to drive strong organic growth in all
our major business segments. We are committed to bringing the right
resources and leadership to ensure our realization of these
important endeavors and are excited to put Seth in a position to
help Cantel take advantage of these important growth drivers."
With more than 20 years of corporate strategy, business
development and investment experience, Mr. Yellin specializes in
expanding healthcare businesses through internal development,
acquisitions, and partnerships. Previously, he served as Executive
Vice President, Strategy & Corporate Development for the
Company. Prior to joining Cantel, Mr. Yellin worked as a healthcare
investment professional most recently at Citadel Global Equities
and as an M&A investment banker at UBS. He holds an MBA from
The Wharton School at the University of
Pennsylvania and an AB from Princeton University.
About Cantel Medical:
Cantel Medical is a leading
global company dedicated to delivering innovative infection
prevention products and services for patients, caregivers, and
other healthcare providers which improve outcomes, enhance safety
and help save lives. Our products include specialized medical
device reprocessing systems for endoscopy and renal dialysis,
advanced water purification equipment, sterilants, disinfectants
and cleaners, sterility assurance monitoring products for hospitals
and dental clinics, disposable infection control products primarily
for dental and GI endoscopy markets, instruments and instrument
reprocessing workflow systems serving the dental industry,
dialysate concentrates, hollow fiber membrane filtration and
separation products. Additionally, we provide technical service for
our products.
For further information, visit www.cantelmedical.com.
View original content to download
multimedia:http://www.prnewswire.com/news-releases/cantel-appoints-seth-yellin-to-chief-growth-officer-301012244.html
SOURCE Cantel Medical Corp.